his issue of Psychiatric Annals, ably guest edited by Dr. Charles B. Nemeroff, focuses on posttraumatic stress disorder (PTSD), presenting a collection of comprehensive articles on diagnosis and neurobiology as well as treatment practices around PTSD.
The first article, "Concerns Over Divergent Approaches in the Diagnostics of Posttraumatic Stress Disorder," by Dr. Eric Vermetten and his colleagues reviews some of the primary arguments and evidence for the diagnosis of PTSD as indicated in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) 1 The final article, entitled "State-of-the-Art Prevention and Treatment of PTSD: Pharmacotherapy, Psychotherapy, and Nonpharmacological Somatic Therapies," by Drs. Nils C. Westfall and Nemeroff is a comprehensive review of PTSD treatment studies across the spectrum of therapeutic modalities and comorbidities.
This issue confirms that we in the psychiatry field have significant improvements to make so patients with PTSD can achieve better health results, as well as the need to prevent comorbid psychologic and cardiovascular illness. Traditional treatment has often involved targeting comorbid conditions, such as mood, anxiety, and substance use disorders; however, the articles in this issue suggest that we need to develop treatment protocols for various types of PTSD, with onsets at different ages. It appears that we may be able to prevent the onset of some cases of PTSD if we can intervene within a certain time window.
AN UPDATE ON MY HEALTH
I hope the summer months have been enjoyable to everyone. For me, I am just finishing a 5-month medical journey. It started out as a "simple" right knee replacement surgery, with a 2-day discharge plan. Instead I experienced atrial fibrillation, over-anticoagulation, bleeding into the surgical site, a re-do of the surgery to avoid infection, and gout attacks. I was then given the beta-blocker metropolol to prevent a stroke, which caused a severe depression.
I had never personally experienced depression or the cognitive limitations before. I was a zombie for about 5 weeks until the beta-blocker was replaced by a calcium-channel blockerflecainide. I had a hard time persuading my "caring" doctors that I needed a change of medication, and wasn't just old and demented. Now, I've been back to work for several weeks, teaching residents in clinics, and recently drove myself to and from work (60 miles) alone for the first time. I still have some pain in my right knee and limited balance, but it's coming along slowly. This is the first long-lasting major medical encounter I have had, so I guess I can call myself lucky!
